The PPARγ is a ligand-activated transcription factor involved in lipid metabolism and homeostasis that has been identified as the molecular target of insulin-sensitizing agents used to treat type 2 diabetes (Smith 2002). The gene discussed is INS; the disease is type 2 diabetes mellitus.